Study of Alofanib in Patients With Metastatic Gastric Cancer
Clinical trial NCT04071184 · UNKNOWN
Trial details
- NCT number
- NCT04071184
- Sponsor
- Russian Pharmaceutical Technologies
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-26
- Primary completion
- 2020-10-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.